Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

• Gene therapy strategies for RAG1 deficiency: Challenges and breakthroughs

  2024 Immunology Letters article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access

  8

  citations
• A comprehensive overview of CRISPR/Cas 9 technology and application thereof in drug discovery

  2022 Journal of Cellular Biochemistry article Biochemistry, Genetics and Molecular Biology CRISPR and Genetic Engineering Open access

  22

  citations
• CRISPR applications for Duchenne muscular dystrophy: From animal models to potential therapies

  2022 WIREs Mechanisms of Disease article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access cited by 1 patent

  23

  citations
• A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies

  2021 Frontiers in Genome Editing article Medicine Hemoglobinopathies and Related Disorders Open access cited by 4 patents

  19

  citations
• Developments in reading frame restoring therapy approaches for Duchenne muscular dystrophy

  2020 Expert Opinion on Biological Therapy article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access

  25

  citations
• CRISPR/Cas with ribonucleoprotein complexes and transiently selected telomere vectors allows highly efficient marker-free and multiple genome editing in Botrytis cinerea

  2020 PLoS Pathogens article Biochemistry, Genetics and Molecular Biology CRISPR and Genetic Engineering Open access cited by 1 patent

  128

  citations
• Meeting a Challenge: A View on Studying Transcriptional Control of Genes Involved in Plant Biomass Degradation in Aspergillus niger

  2020 Grand challenges in biology and biotechnology book-chapter Biochemistry, Genetics and Molecular Biology Fungal and yeast genetics research

  2

  citations

7 results